Mariotti J, Pinton C, Giordano L, Taurino D, et al. Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis. Br J Haematol 2025 Aug 31. doi: 10.1111/bjh.70091.
PMID: 40887735